Source: AAPS Author: Peter McCullough
From the Association of American Physicians and Surgeons:
It is our honor to bring Dr. McCullough back to “Doctors Are In” to discuss the latest on reducing COVID-19 hospitalization and death with early treatment with an in depth overview and update on ambulatory treatment studies and the new sequenced, multi-drug therapeutic regimen for high-risk COVID-19 patients.
It was also an honor to hear from Senator Bob Hall about his efforts to protect patient access to early treatment options.
See the report in ‘Reviews in Cardiovascular Medicine’ here:
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin